COMPARE · Reviewed July 29, 2026
CF vs IOSP
Verdict: Side-by-side breakdown using the Bull Rankings model. CF scored 59.0, IOSP scored 61.1 — IOSP leads.
Compare another set
CF
CF Industries Holdings, Inc.
59
$125.96 · $19.4B
fundamentals as of
Score gap
2.1
IOSP leads
IOSP
Innospec Inc.
61.1
$85.31 · $2.1B
fundamentals as of
The model, pillar by pillar (0–100 each)
CF
stronger →← stronger
IOSP
89
Qualityreturns · margins · balance sheet
65
50
Growthrevenue & earnings expansion
50
46
Valuevaluation vs sector peers
71
CF and IOSP split the three pillars evenly.
Fundamentals, head-to-head
CF
IOSP
$1.6bC+
FCF
$110mC
+20.9%A-
Rev
+0.2%C
0.44B
D/E
0.04A-
11.3xA-
P/E
18.6xB
3.59D
PEG
0.66A-
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
CF
IOSP
2% below
Price vs fair valuelower is cheaper
24% below
~-2%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
+14%
1-yr DCF upside
+0%
+2%
5-yr DCF upside
+32%
-12%
10-yr DCF upside
+98%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CF
Why this score
- Buying back stock
- Cyclical growth
IOSP
Why this score
- Raising its dividend
- Durable high returns
- Cyclical growth
The companies
CFCF Industries Holdings, Inc.
Why now
Agricultural Inputs · market cap $19.4b. 11% off the 52-week high of $141.96. Revenue growing +21%, comfortably above the S&P median. 19 sell-side analysts rate this a Hold with a mean 1-yr target of $125.25 (implying -1% upside).
Moat
Net margin 29% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 40% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
IOSPInnospec Inc.
Why now
Specialty Chemicals · market cap $2.1b. 7% off the 52-week high of $92.14. PEG 0.66 — paying under fair value for the growth rate. 3 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $99.33 (implying +16% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.